The IPKat

Falling between the cracks: The challenges of patent strategy for stem cell therapies (T 1259/22)

The difference between the credibility and the unambiguous disclosure of a therapeutic effect (T 0209/22)

Make no bones about it: The "credibility test" has no place in the novelty assessment of second medical use claims (T 0558/20)